MedTrace Logo

N-Acetyl Cysteine After Cervical Cerclage

NCT00787813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2008-11-20

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of N-acetyl cysteine (NAC) on pregnancy outcome in women undergoing cervical cerclage for cervical insufficiency.

Conditions

  • Cervical Cerclage

Interventions

DRUG

N-Acetyl Cysteine

oral daily dose of 0.6 g of N-acetyl cysteine in effervescent form

DRUG

Placebo

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • AHMED M NASR, MD · Women's Health Center, Assiut University, EGYPT

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-10-31
Completion
2008-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00787813 on ClinicalTrials.gov